Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology
Founded in 2017 as an AI research company, Unlearn has always been at the forefront of developing innovative AI-based solutions for clinical trials.
- Founded in 2017 as an AI research company, Unlearn has always been at the forefront of developing innovative AI-based solutions for clinical trials.
- Unlearn’s AI models generate an individual digital twin for every trial participant before they are randomized into the experimental or control arm.
- “Breaking down these barriers and proving the value of digital twin technology continues to be a main driver for us at Unlearn.
- “Unlearn is introducing powerful AI models to help make clinical research more streamlined and efficient,” said Pauline Yang, Partner at Altimeter Capital.